Profund Advisors LLC Uni Qure N.V. Transaction History

Profund Advisors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$5.63 - $8.27 $33,695 - $49,495	-5,985 Reduced 9.33%	58,187 $393,000
Q3 2023 Nov 13, 2023	BUY	$6.71 - $11.83 $183,552 - $323,609	27,355 Added 74.3%	64,172 $430,000
Q2 2023 Aug 10, 2023	SELL	$11.12 - $22.2 $44,713 - $89,266	-4,021 Reduced 9.85%	36,817 $421,000
Q1 2023 May 11, 2023	BUY	$18.7 - $23.07 $763,670 - $942,132	40,838 New	40,838 $822,000

142

35.3M

1.54M

389K

Ticker QURE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,729,100
Market Cap $300M
Description
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...

Get notified when there are updates to the investment portfolio of Profund Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Profund Advisors LLC with notifications on news.